The Healthcare Data

Vyome Holdings Expands Leadership Team Ahead of Pivotal Trials

Vyome Holdings Strengthens Leadership Team with Strategic Appointments Ahead of Pivotal Clinical Studies Vyome Holdings, Inc. (NASDAQ: HIND), a clinical-stage healthcare holding company focused on advancing next-generation therapies, has announced two high-profile leadership appointments as it prepares to enter pivotal…

FDA Clears Pulse Biosciences to Begin nsPFA AFib Trial

Pulse Biosciences Secures FDA IDE Approval to Launch nsPFA Cardiac Surgery Study for Atrial Fibrillation Treatment Pulse Biosciences, Inc. (Nasdaq: PLSE), a medical technology company pioneering nonthermal ablation therapies through its proprietary Nanosecond Pulsed Field Ablation™ (nsPFA™) platform, has reached…